Ind-Swift Laboratories is trading 5.1% up at INR 236.94 after the company announced a board meeting scheduled for July 10, 2026, to consider raising funds via equity or other securities.
- The board will evaluate various capital-raising options to support the company's growth objectives and future expansion.
- The stock has maintained an upward trend over the past week as investors react to the potential capital infusion and associated growth expectations.